Rare diseases
Investigational molecules
Locations
Back to Germany11 clinical trials in Bergisch Gladbach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer treatments, exploring new therapeutic combinations to improve patient outcomes.
Studies evaluating breakthrough medications like ribociclib, elacestrant, and abemaciclib in combination with standard treatments.
Comprehensive research targeting metastatic prostate cancer, including both castration-resistant and castration-sensitive forms of the disease.
Trials examining innovative treatments including darolutamide and new therapeutic protocols for different stages of disease progression.
Studies addressing treatment-related side effects, particularly focusing on vasomotor symptoms in cancer patients undergoing hormone therapy.
Investigation of new compounds like elinzanetant for managing therapy-induced symptoms in cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
